DE3876039T2 - Verfahren zur herstellung von optisch aktiven verbindungen mit pyridin-kernen. - Google Patents

Verfahren zur herstellung von optisch aktiven verbindungen mit pyridin-kernen.

Info

Publication number
DE3876039T2
DE3876039T2 DE8888112789T DE3876039T DE3876039T2 DE 3876039 T2 DE3876039 T2 DE 3876039T2 DE 8888112789 T DE8888112789 T DE 8888112789T DE 3876039 T DE3876039 T DE 3876039T DE 3876039 T2 DE3876039 T2 DE 3876039T2
Authority
DE
Germany
Prior art keywords
optically active
active connections
producing optically
cores
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888112789T
Other languages
English (en)
Other versions
DE3876039D1 (de
Inventor
Masakazu Kaneoya
Naoyuki Yoshida
Manabu Uchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
Chisso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp filed Critical Chisso Corp
Application granted granted Critical
Publication of DE3876039D1 publication Critical patent/DE3876039D1/de
Publication of DE3876039T2 publication Critical patent/DE3876039T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
DE8888112789T 1987-08-28 1988-08-05 Verfahren zur herstellung von optisch aktiven verbindungen mit pyridin-kernen. Expired - Fee Related DE3876039T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62212674A JP2691986B2 (ja) 1987-08-28 1987-08-28 ピリジン骨格を有する光学活性化合物の製造法

Publications (2)

Publication Number Publication Date
DE3876039D1 DE3876039D1 (de) 1992-12-24
DE3876039T2 true DE3876039T2 (de) 1993-04-22

Family

ID=16626522

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888112789T Expired - Fee Related DE3876039T2 (de) 1987-08-28 1988-08-05 Verfahren zur herstellung von optisch aktiven verbindungen mit pyridin-kernen.

Country Status (4)

Country Link
US (1) US4971909A (de)
EP (1) EP0304706B1 (de)
JP (1) JP2691986B2 (de)
DE (1) DE3876039T2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2578658B2 (ja) * 1989-02-21 1997-02-05 チッソ株式会社 光学活性化合物及びその製造法
JP2542941B2 (ja) * 1990-02-02 1996-10-09 チッソ株式会社 光学活性ヒドロキシラクトン類の製造方法
US5126268A (en) * 1990-03-30 1992-06-30 Eastman Kodak Company Alcohol-ester sparation by reaction with acetate
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
KR100244728B1 (ko) * 1992-08-31 2000-03-02 스즈키 타다오 광학활성 1,4-디히드로피리딘 화합물 및 그의 제조방법
AT401385B (de) * 1994-03-30 1996-08-26 Chemie Linz Gmbh Enzymatische racematspaltung asymmetrischer alkohole mittels vinylestern mehrbasiger carbonsäuren
DE4414273A1 (de) * 1994-04-23 1995-10-26 Chemie Linz Deutschland Enzymatische Racematspaltung asymmetrischer Alkohole mittels Vinylestern mehrbasiger Carbonsäuren
EP0725146A4 (de) * 1994-07-18 1998-12-23 Daicel Chem Verfahren zur herstellung optischaktiver triazolverbindungen und methode zur razemisierung optischaktiver triazolverbindungen
DE19809649A1 (de) * 1998-03-06 1999-09-09 Hoechst Marion Roussel De Gmbh Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester
MX2017013383A (es) 2015-04-20 2017-12-07 Tolero Pharmaceuticals Inc Prediccion de respuesta a alvocidib mediante perfilado mitocondrial.
KR102608921B1 (ko) 2015-05-18 2023-12-01 스미토모 파마 온콜로지, 인크. 생체 이용률이 증가된 알보시딥 프로드러그
MX2018001289A (es) 2015-08-03 2018-04-30 Tolero Pharmaceuticals Inc Terapias de combinacion para el tratamiento del cancer.
US11279694B2 (en) 2016-11-18 2022-03-22 Sumitomo Dainippon Pharma Oncology, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
WO2019055579A1 (en) 2017-09-12 2019-03-21 Tolero Pharmaceuticals, Inc. TREATMENT REGIME FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 ALVOCIDIB INHIBITOR
ES2910071T3 (es) 2018-03-08 2022-05-11 Incyte Corp Compuestos de aminopirazina diol como inhibidores de PI3K-Y
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
MX2021006544A (es) 2018-12-04 2021-07-07 Sumitomo Pharma Oncology Inc Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer.
WO2020191326A1 (en) 2019-03-20 2020-09-24 Sumitomo Dainippon Pharma Oncology, Inc. Treatment of acute myeloid leukemia (aml) with venetoclax failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1215924A (en) * 1983-07-27 1986-12-30 David W. Bewick Process for producing optically active aryloxypropionic acids and derivatives thereof useful as herbicides
US4916074A (en) * 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds

Also Published As

Publication number Publication date
DE3876039D1 (de) 1992-12-24
EP0304706A3 (en) 1990-07-04
EP0304706B1 (de) 1992-11-19
JPS6460398A (en) 1989-03-07
JP2691986B2 (ja) 1997-12-17
US4971909A (en) 1990-11-20
EP0304706A2 (de) 1989-03-01

Similar Documents

Publication Publication Date Title
DE3783327T2 (de) Verfahren zur herstellung von optisch aktiven verbindungen.
DE3868138D1 (de) Verfahren zur herstellung von quaternaeren salzen.
DE3884507D1 (de) Verfahren zur herstellung von optisch aktiven sekundaeren aminen.
DE3876039T2 (de) Verfahren zur herstellung von optisch aktiven verbindungen mit pyridin-kernen.
DE3866906D1 (de) Verfahren zur herstellung von polyolefinen.
DE3872924D1 (de) Verfahren zur herstellung von optisch aktiven verbindungen.
DE3869308D1 (de) Verfahren zur herstellung von kieselglas.
DE3853160D1 (de) Verfahren zur herstellung von elektrophotographien.
DE3865476D1 (de) Verfahren zur herstellung von aminopropylalkoxysilanen.
DE3860666D1 (de) Verfahren zur herstellung von hexabromcyclododekan.
DE3881064D1 (de) Verfahren zur herstellung von kristallinen komplexen perovskit-verbindungen.
DE3861891D1 (de) Verfahren zur herstellung von epichlorhydrinen.
DE3863586D1 (de) Verfahren zur herstellung von m-triflourmethylphenylacetonitril.
DE3882167D1 (de) Verfahren zur herstellung von fluorbenzaldehyden.
DE3851218D1 (de) Verfahren zur herstellung optisch aktiver verbindungen.
DE3884577D1 (de) Verfahren zur herstellung von polyolefinen.
DE3878203D1 (de) Verfahren zur herstellung von 2-amino-2-deoxy-d-mannit.
DE3863321D1 (de) Verfahren zur herstellung von naphthacenen.
DE3868798D1 (de) Verfahren zur herstellung von m-benzyltoluol.
DE68906372T2 (de) Verfahren zur herstellung von optisch aktiven threo-dihydroxyphenylserine-derivaten.
DE3872100D1 (de) Verfahren zur herstellung von phenylaethanolaminotetralinen.
DE68908129D1 (de) Verfahren zur herstellung von optisch aktivem carnitinester.
DE3885823D1 (de) Verfahren zur herstellung von 3-chlor-4-fluornitrobenzol.
DE3884488D1 (de) Verfahren zur herstellung von 2-arylthiobenzoesaeuren.
DE3878122T2 (de) Verfahren zur herstellung von anilinofumaraten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee